Comments on: GW Pharmaceuticals Announces Second Positive Phase 3 Pivotal Trial for EPIDIOLEX® (cannabidiol) oral solution CV in Patients with Dravet Syndrome https://mjshareholders.com/gw-pharmaceuticals-announces-second-positive-phase-3-pivotal-trial-for-epidiolex-cannabidiol-oral-solution-cv-in-patients-with-dravet-syndrome/ The Ultimate Marijuana Business Directory Tue, 27 Nov 2018 04:45:58 +0000 hourly 1 https://wordpress.org/?v=6.5.4